These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 23378723)

  • 1. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
    Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
    Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum N(ε)-Carboxy methyl lysine with severity of diabetic retinopathy.
    Mishra N; Saxena S; Shukla RK; Singh V; Meyer CH; Kruzliak P; Khanna VK
    J Diabetes Complications; 2016 Apr; 30(3):511-7. PubMed ID: 26782022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of N(ε)- Carboxy methyl lysine (N(ε)-CML) are associated with topographic alterations in retinal pigment epithelium: A preliminary study.
    Mishra N; Saxena S; Ruia S; Prasad S; Singh V; Khanna V; Staffa R; Gaspar L; Kruzliak P
    J Diabetes Complications; 2016 Jul; 30(5):868-72. PubMed ID: 27039312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress-associated neuroretinal dysfunction and nitrosative stress in diabetic retinopathy.
    Mandal LK; Choudhuri S; Dutta D; Mitra B; Kundu S; Chowdhury IH; Sen A; Chatterjee M; Bhattacharya B
    Can J Diabetes; 2013 Dec; 37(6):401-7. PubMed ID: 24321721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
    Fokkens BT; Mulder DJ; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    PLoS One; 2017; 12(3):e0173379. PubMed ID: 28264049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy.
    Nakamura N; Hasegawa G; Obayashi H; Yamazaki M; Ogata M; Nakano K; Yoshikawa T; Watanabe A; Kinoshita S; Fujinami A; Ohta M; Imamura Y; Ikeda T
    Diabetes Res Clin Pract; 2003 Aug; 61(2):93-101. PubMed ID: 12951277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema.
    Boehm BO; Schilling S; Rosinger S; Lang GE; Lang GK; Kientsch-Engel R; Stahl P
    Diabetologia; 2004 Aug; 47(8):1376-9. PubMed ID: 15258735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.
    Katagiri M; Shoji J; Inada N; Kato S; Kitano S; Uchigata Y
    Int Ophthalmol; 2018 Apr; 38(2):607-615. PubMed ID: 28299499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.
    Kerkeni M; Saïdi A; Bouzidi H; Ben Yahya S; Hammami M
    Microvasc Res; 2012 Nov; 84(3):378-83. PubMed ID: 22835520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization.
    Swamy-Mruthinti S; Miriam KC; Kumar SK; Biswas J; Ramakrishnan S; Nagaraj RH; Sulochana KN
    Curr Eye Res; 2002 Sep; 25(3):139-45. PubMed ID: 12607183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of hyperglycemia mediated increased advanced glycation and erythrocyte antioxidant enzyme activity in different stages of diabetic retinopathy.
    Choudhuri S; Dutta D; Chowdhury IH; Mitra B; Sen A; Mandal LK; Mukhopadhyay S; Bhattacharya B
    Diabetes Res Clin Pract; 2013 Jun; 100(3):376-84. PubMed ID: 23602454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between vitreous levels of soluble receptor for advanced glycation end products (sRAGE) and renal function in patients with diabetic retinopathy.
    Katagiri M; Shoji J; Kato S; Kitano S; Uchigata Y
    Int Ophthalmol; 2017 Dec; 37(6):1247-1255. PubMed ID: 27830398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of vitreous humor chemokines in type 2 diabetic patients with and without diabetic retinopathy.
    Zeng Y; Cao D; Yu H; Hu Y; He M; Yang D; Zhuang X; Zhang L
    Acta Diabetol; 2019 Jul; 56(7):797-805. PubMed ID: 30911832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
    Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
    J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
    Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
    Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
    Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
    Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes-induced oxidative stress in the vitreous humor.
    Géhl Z; Bakondi E; Resch MD; Hegedűs C; Kovács K; Lakatos P; Szabó A; Nagy Z; Virág L
    Redox Biol; 2016 Oct; 9():100-103. PubMed ID: 27454767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function.
    Wagner Z; Wittmann I; Mazák I; Schinzel R; Heidland A; Kientsch-Engel R; Nagy J
    Am J Kidney Dis; 2001 Oct; 38(4):785-91. PubMed ID: 11576882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.